Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Graft versus host disease

Recruiting

Registered drugNo placebo

Study on Graft-Versus-Host Disease Prevention Using Cyclophosphamide and Methotrexate in Adults with Blood Cancer Undergoing Matched-Donor Transplant

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Busulfan

Contact Research Centre

Graft versus host disease+1

Recruiting

Registered drugNo placebo

Long-term Study of Ibrutinib for Patients with B-cell Non-Hodgkin's Lymphoma and Chronic Graft Versus Host Disease

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Graft versus host disease

Not yet recruiting

InvestigationalNo placebo

A study to evaluate the effectiveness of MC0518 (mesenchymal stromal cells) in adults with acute graft-versus-host disease that has not responded to steroids and ruxolitinib

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Mesenchymal Stromal Cells, Ex Vivo Cultured

Contact Research Centre

Graft versus host disease

Not yet recruiting

Registered drugNo placebo

Safety and Efficacy of MaaT013 with Vancomycin in Children and Adolescents with Gastrointestinal Acute Graft‑versus‑Host Disease

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years
Substances:Vancomycin

Contact Research Centre

Graft versus host disease

Not yet recruiting

InvestigationalNo placebo

Study of Mesenchymal Stromal Cells expressing CXCR4 and IL-10 for patients with acute Graft Versus Host Disease who do not respond to steroids or ruxolitinib

InvestigationalNo placebo

Spain

Participants:18–64 years
Substances:ALLOGENEIC ADIPOCYTE-DERIVED MESENCHYMAL STROMAL CELLS TRANSDUCED WITH A LENTIVIRAL PROVIRUS VECTOR CONTAINING THE HUMAN CXCR4 AND IL-10 GENES

Contact Research Centre

Graft versus host disease+10

Not recruiting

InvestigationalNo placebo

Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Graft versus host disease+1

Not recruiting

Investigational

Study of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Itolizumab

Contact Research Centre

Graft versus host disease+1

Not recruiting

Registered drugNo placebo

Comparison of Post-Transplant Cyclophosphamide versus Anti-T Lymphocyte Immunoglobulin for Prevention of Graft versus Host Disease in Patients Receiving Unrelated Donor Transplantation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Graft versus host disease

Not recruiting

InvestigationalNo placebo

Study on the Safety of Decidua Stromal Cells for Patients with Steroid-Resistant Severe Acute Graft vs Host Disease

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Allogeneic Placenta-Derived Decidual Stromal Cells, Ex-Vivo Expanded

Contact Research Centre

Graft versus host disease

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Human Alpha1-Proteinase Inhibitor for Preventing Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplant.

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Human Alpha1-Proteinase Inhibitor

Contact Research Centre

Find therapies in clinical trials near you

10 trials match your criteria

Graft versus host disease

Study on Graft-Versus-Host Disease Prevention Using Cyclophosphamide and Methotrexate in Adults with Blood Cancer Undergoing Matched-Donor Transplant

Graft versus host disease+1

Long-term Study of Ibrutinib for Patients with B-cell Non-Hodgkin's Lymphoma and Chronic Graft Versus Host Disease

Graft versus host disease

A study to evaluate the effectiveness of MC0518 (mesenchymal stromal cells) in adults with acute graft-versus-host disease that has not responded to steroids and ruxolitinib

Graft versus host disease

Safety and Efficacy of MaaT013 with Vancomycin in Children and Adolescents with Gastrointestinal Acute Graft‑versus‑Host Disease

Graft versus host disease

Study of Mesenchymal Stromal Cells expressing CXCR4 and IL-10 for patients with acute Graft Versus Host Disease who do not respond to steroids or ruxolitinib

Graft versus host disease+10

Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

Graft versus host disease+1

Study of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant

Graft versus host disease+1

Comparison of Post-Transplant Cyclophosphamide versus Anti-T Lymphocyte Immunoglobulin for Prevention of Graft versus Host Disease in Patients Receiving Unrelated Donor Transplantation

Graft versus host disease

Study on the Safety of Decidua Stromal Cells for Patients with Steroid-Resistant Severe Acute Graft vs Host Disease

Graft versus host disease

Study on the Safety and Effectiveness of Human Alpha1-Proteinase Inhibitor for Preventing Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplant.

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.